Ewing Sarcoma clinical trials

Explore recruiting ewing sarcoma clinical trials.

Recruiting ewing sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ewing Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very High-Risk Ewing Sarcoma.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

INTER-EWING-1: International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma – Trial 1

Denmark, Spain, Netherlands, Norway, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label, Multicenter, First-in-Human, Phase 1 Dose Escalation and Multicohort Expansion Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors, Including Sarcomas.

France, Italy, Netherlands, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma

Sweden, Germany, Austria, Czechia

Human Pharmacology (Phase I)- Other EU CTIS Study details

International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma

Germany, Greece, Austria, Poland, Belgium, Finland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Ewing Sarcoma trials by city

Ewing Sarcoma in Toronto Ewing Sarcoma in Vancouver Ewing Sarcoma in Montreal Ewing Sarcoma in Calgary Ewing Sarcoma in Edmonton Ewing Sarcoma in Ottawa Ewing Sarcoma in Winnipeg Ewing Sarcoma in Quebec City Ewing Sarcoma in Hamilton Ewing Sarcoma in Kitchener Ewing Sarcoma in London Ewing Sarcoma in Halifax Ewing Sarcoma in New York Ewing Sarcoma in Los Angeles Ewing Sarcoma in Chicago Ewing Sarcoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease